CLGN
Price
$1.90
Change
-$0.14 (-6.86%)
Updated
May 22, 12:08 PM (EDT)
Capitalization
23.37M
6 days until earnings call
CLLS
Price
$1.53
Change
+$0.01 (+0.66%)
Updated
May 22, 12:26 PM (EDT)
Capitalization
151.23M
70 days until earnings call
Interact to see
Advertisement

CLGN vs CLLS

Header iconCLGN vs CLLS Comparison
Open Charts CLGN vs CLLSBanner chart's image
CollPlant Biotechnologies
Price$1.90
Change-$0.14 (-6.86%)
Volume$400
Capitalization23.37M
Cellectis SA
Price$1.53
Change+$0.01 (+0.66%)
Volume$100
Capitalization151.23M
CLGN vs CLLS Comparison Chart
Loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLGN vs. CLLS commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a Hold and CLLS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (CLGN: $2.04 vs. CLLS: $1.52)
Brand notoriety: CLGN and CLLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 42% vs. CLLS: 68%
Market capitalization -- CLGN: $23.37M vs. CLLS: $151.23M
CLGN [@Biotechnology] is valued at $23.37M. CLLS’s [@Biotechnology] market capitalization is $151.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green whileCLLS’s FA Score has 1 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • CLLS’s FA Score: 1 green, 4 red.
According to our system of comparison, CLLS is a better buy in the long-term than CLGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 4 TA indicator(s) are bullish.

  • CLLS’s TA Score: 4 bullish, 5 bearish.

Price Growth

CLGN (@Biotechnology) experienced а +24.77% price change this week, while CLLS (@Biotechnology) price change was +10.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.18%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was -1.65%.

Reported Earning Dates

CLGN is expected to report earnings on Aug 21, 2025.

CLLS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($151M) has a higher market cap than CLGN($23.4M). CLLS YTD gains are higher at: -15.556 vs. CLGN (-43.333). CLLS has higher annual earnings (EBITDA): -9.46M vs. CLGN (-17.27M). CLLS has more cash in the bank: 260M vs. CLGN (15.4M). CLGN has less debt than CLLS: CLGN (3.25M) vs CLLS (91.5M). CLLS has higher revenues than CLGN: CLLS (41.5M) vs CLGN (650K).
CLGNCLLSCLGN / CLLS
Capitalization23.4M151M15%
EBITDA-17.27M-9.46M182%
Gain YTD-43.333-15.556279%
P/E RatioN/AN/A-
Revenue650K41.5M2%
Total Cash15.4M260M6%
Total Debt3.25M91.5M4%
FUNDAMENTALS RATINGS
CLGN vs CLLS: Fundamental Ratings
CLGN
CLLS
OUTLOOK RATING
1..100
259
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9461
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLLS's Valuation (24) in the Biotechnology industry is significantly better than the same rating for CLGN (94). This means that CLLS’s stock grew significantly faster than CLGN’s over the last 12 months.

CLLS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CLGN (100). This means that CLLS’s stock grew similarly to CLGN’s over the last 12 months.

CLLS's SMR Rating (100) in the Biotechnology industry is in the same range as CLGN (100). This means that CLLS’s stock grew similarly to CLGN’s over the last 12 months.

CLLS's Price Growth Rating (61) in the Biotechnology industry is somewhat better than the same rating for CLGN (94). This means that CLLS’s stock grew somewhat faster than CLGN’s over the last 12 months.

CLGN's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for CLLS (100). This means that CLGN’s stock grew significantly faster than CLLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLLS
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIDRX9.57N/A
N/A
Lord Abbett International Value R2
FCDTX32.82N/A
N/A
Fidelity Advisor Stock Selector Sm Cp M
SMFPX10.27N/A
N/A
Westwood Salient MLP & Engy Infras C
SEPCX9.24N/A
N/A
Saratoga Energy & Basic Materials C
FWOMX17.02N/A
N/A
Fidelity Women's Leadership

CLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLGN has been loosely correlated with CMVLF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLGN jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
+3.03%
CMVLF - CLGN
37%
Loosely correlated
N/A
CLLS - CLGN
33%
Poorly correlated
-1.30%
VOR - CLGN
25%
Poorly correlated
+2.35%
INTS - CLGN
24%
Poorly correlated
-9.59%
CVAC - CLGN
24%
Poorly correlated
-8.88%
More

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been closely correlated with CMVLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLLS jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
-1.30%
CMVLF - CLLS
82%
Closely correlated
N/A
ABCZF - CLLS
58%
Loosely correlated
N/A
SLN - CLLS
43%
Loosely correlated
N/A
MDGL - CLLS
40%
Loosely correlated
-5.30%
PMVP - CLLS
38%
Loosely correlated
-3.16%
More